| Christopher A Dixon, DO | |
|
9104 Market St, Wilmington, NC 28411-7994 | |
| (910) 686-2840 | |
| Not Available |
| Full Name | Christopher A Dixon |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 25 Years |
| Location | 9104 Market St, Wilmington, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366447344 | NPI | - | NPPES |
| 89136RF | Medicaid | NC | |
| 2401832E | Other | NC | MEDICARE PTAN |
| 2401832C | Other | NC | MEDICARE PTAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 200301107 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| New Hanover Regional Medical Center | Wilmington, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| American Anesthesiology Of North Carolina Pllc | 2961316450 | 383 |
| Southeast Anesthesiology Consultants Pllc | 7719959873 | 84 |
News Archive
An international team of researchers led by a Case Western Reserve University School of Medicine scientist has uncovered a novel mechanism in which a protein-neuregulin 3-controls how key neurotransmitters are released in the brain during schizophrenia.
Being at the top has its perks, but new UofT research shows people in positions of authority at work are more likely to experience certain psychological and physical problems that can undermine the health benefits associated with job authority.
Inequality in the use of health care has increased dramatically in recent years, with wealthier Americans, who tend to be healthier, now consuming the most care, according to a study published today [Wednesday, July 6] in the July issue of Health Affairs.
AbbVie, a global biopharmaceutical company, today announced that results from a Phase 1b trial of investigational venetoclax, a novel inhibitor of the B-cell lymphoma-2 (BCL-2) protein that is being developed in partnership with Genentech and Roche, in combination with bortezomib and dexamethasone, showed an 83 percent overall response rate (n=5/6) in bortezomib-naive patients with relapsed/refractory (R/R) multiple myeloma, including two patients who achieved complete responses.1 These data will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting on Sunday, May 31, in Chicago.
The EU-funded CASBLiP project was conceived to integrate the image processing and acoustic mapping technologies into a single, portable device that could be worn by blind people and help them to navigate outdoors.
› Verified 6 days ago
| Entity Name | American Anesthesiology Of North Carolina Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033412267 PECOS PAC ID: 2961316450 Enrollment ID: O20031118000860 |
News Archive
An international team of researchers led by a Case Western Reserve University School of Medicine scientist has uncovered a novel mechanism in which a protein-neuregulin 3-controls how key neurotransmitters are released in the brain during schizophrenia.
Being at the top has its perks, but new UofT research shows people in positions of authority at work are more likely to experience certain psychological and physical problems that can undermine the health benefits associated with job authority.
Inequality in the use of health care has increased dramatically in recent years, with wealthier Americans, who tend to be healthier, now consuming the most care, according to a study published today [Wednesday, July 6] in the July issue of Health Affairs.
AbbVie, a global biopharmaceutical company, today announced that results from a Phase 1b trial of investigational venetoclax, a novel inhibitor of the B-cell lymphoma-2 (BCL-2) protein that is being developed in partnership with Genentech and Roche, in combination with bortezomib and dexamethasone, showed an 83 percent overall response rate (n=5/6) in bortezomib-naive patients with relapsed/refractory (R/R) multiple myeloma, including two patients who achieved complete responses.1 These data will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting on Sunday, May 31, in Chicago.
The EU-funded CASBLiP project was conceived to integrate the image processing and acoustic mapping technologies into a single, portable device that could be worn by blind people and help them to navigate outdoors.
› Verified 6 days ago
| Entity Name | Southeast Anesthesiology Consultants Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538124201 PECOS PAC ID: 7719959873 Enrollment ID: O20040809001398 |
News Archive
An international team of researchers led by a Case Western Reserve University School of Medicine scientist has uncovered a novel mechanism in which a protein-neuregulin 3-controls how key neurotransmitters are released in the brain during schizophrenia.
Being at the top has its perks, but new UofT research shows people in positions of authority at work are more likely to experience certain psychological and physical problems that can undermine the health benefits associated with job authority.
Inequality in the use of health care has increased dramatically in recent years, with wealthier Americans, who tend to be healthier, now consuming the most care, according to a study published today [Wednesday, July 6] in the July issue of Health Affairs.
AbbVie, a global biopharmaceutical company, today announced that results from a Phase 1b trial of investigational venetoclax, a novel inhibitor of the B-cell lymphoma-2 (BCL-2) protein that is being developed in partnership with Genentech and Roche, in combination with bortezomib and dexamethasone, showed an 83 percent overall response rate (n=5/6) in bortezomib-naive patients with relapsed/refractory (R/R) multiple myeloma, including two patients who achieved complete responses.1 These data will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting on Sunday, May 31, in Chicago.
The EU-funded CASBLiP project was conceived to integrate the image processing and acoustic mapping technologies into a single, portable device that could be worn by blind people and help them to navigate outdoors.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christopher A Dixon, DO 3100 Spring Forest Rd, Suite 130, Raleigh, NC 27616-2880 Ph: (919) 882-0706 | Christopher A Dixon, DO 9104 Market St, Wilmington, NC 28411-7994 Ph: (910) 686-2840 |
News Archive
An international team of researchers led by a Case Western Reserve University School of Medicine scientist has uncovered a novel mechanism in which a protein-neuregulin 3-controls how key neurotransmitters are released in the brain during schizophrenia.
Being at the top has its perks, but new UofT research shows people in positions of authority at work are more likely to experience certain psychological and physical problems that can undermine the health benefits associated with job authority.
Inequality in the use of health care has increased dramatically in recent years, with wealthier Americans, who tend to be healthier, now consuming the most care, according to a study published today [Wednesday, July 6] in the July issue of Health Affairs.
AbbVie, a global biopharmaceutical company, today announced that results from a Phase 1b trial of investigational venetoclax, a novel inhibitor of the B-cell lymphoma-2 (BCL-2) protein that is being developed in partnership with Genentech and Roche, in combination with bortezomib and dexamethasone, showed an 83 percent overall response rate (n=5/6) in bortezomib-naive patients with relapsed/refractory (R/R) multiple myeloma, including two patients who achieved complete responses.1 These data will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting on Sunday, May 31, in Chicago.
The EU-funded CASBLiP project was conceived to integrate the image processing and acoustic mapping technologies into a single, portable device that could be worn by blind people and help them to navigate outdoors.
› Verified 6 days ago
Thomas M Dalton, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2131 S 17th St, Wilmington, NC 28401 Phone: 910-442-1100 Fax: 910-442-1199 | |
Mrs. Chelsea Blanchard, CRNA Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2131 S 17th St, Wilmington, NC 28401 Phone: 910-667-7000 | |
Barry D Amos, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2131 S 17th St, Wilmington, NC 28401 Phone: 910-442-1100 Fax: 910-442-1199 | |
Charles L Joachim, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 309 Bridgeton Ct, Wilmington, NC 28411 Phone: 910-681-1262 | |
Virgil E Bean, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2131 S 17th St, Wilmington, NC 28401 Phone: 910-442-1100 Fax: 910-442-1199 | |
Dr. Mark Christian Grieb, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1801 S 17th St, Wilmington, NC 28401 Phone: 910-763-4555 Fax: 910-798-8923 | |
John S Pace, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 2131 S 17th St, Wilmington, NC 28401 Phone: 910-442-1100 Fax: 910-442-1199 |